A simple blood sample (8ml) from pregnant women at 10^ week of gestation is required.
The PrenatalSAFE®Karyo test is non-invasive and, for this reason, it is completely safe for the patient and the fetus. The risk of a spontaneous miscarriage related with the traditional invasive pre-natal diagnostic techniques, such as amniocentesis and villocentesis, is thus avoided.
We have introduced a high-resolution FAST technology, which provides test results within only 5 working days, while maintaining the same levels of sensitivity and specificity as for the standard test.
The test has demonstrated a sensitivity >99% in detecting chromosome aneuploidies (trisomy 21, trisomy 18, trisomy 13, Monosomy X), with a false positive rate <0.1%.